Health Trials

Relapsed Advanced Lymphomas

2

Review clinical trials related to Relapsed Advanced Lymphomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

An open-label, first-in-human, Phase 1 study in adult patients with relapsed advanced lymphomas will be done to assess AUR108 safety, tolerability, pharmacokinetics, pharmacodynamics, and optimal biological dose.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-99Biological sex: AllType: InterventionalSponsor: Aurigene Discovery Technologies LimitedUpdated: Apr 17, 2026Locations: 27
Eligibility criteria

Males or females ≥ 18 years of age [+16]

Systemic anti-cancer therapy, such as chemotherapy, or biological therapy, immun... [+23]

Read more
Status: Recruiting

Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma

A Phase 1, Open Label, Dose Escalation, Multicenter, First-in-Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR112 in Patients with Relapsed Advanced Lymphoma (ADITI-1)

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-99Biological sex: AllType: InterventionalSponsor: Aurigene Discovery Technologies LimitedUpdated: Jan 13, 2026Locations: 19
Eligibility criteria

Males and females ≥ 18 years of age [+15]

Systemic anti-cancer therapy, such as chemotherapy, biological therapy, or immun... [+21]

Read more